Funder
European Foundation for the Study of Diabetes
Magnus Bergvall Foundation
Swedish Research Council
Barndiabetesfondens
Reference31 articles.
1. Fibrotic disease and the TH1/TH2 paradigm;Wynn;Nat. Rev. Immunol.,2004
2. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis;J. Hepatol.,2015
3. Limitations of non-invasive tests for assessment of liver fibrosis;Patel;JHEP Rep.,2020
4. Utilization rates, complications and costs of percutaneous liver biopsy: a population-based study including 4275 biopsies;Myers;Liver Int.,2008
5. Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis;Pinzani;Am. J. Pathol.,1996